Upregulation of Rpn10 promotes tumor progression via activation of the NF-κB pathway in clear cell renal cell carcinoma

被引:2
作者
Huang, Tingting [1 ]
Tian, Wei [1 ]
Zhou, Qingqing [1 ]
Li, Jiajun [1 ]
Jiang, Zhiyuan [1 ]
Chen, Jinsi [1 ]
Ge, Chao [1 ]
Tian, Hua [1 ]
机构
[1] Shanghai Jiao Tong Univ, Renji Hosp, Shanghai Canc Inst, State Key Lab Oncogenes & Related Genes,Sch Med, Shanghai 200032, Peoples R China
基金
上海市自然科学基金; 中国国家自然科学基金;
关键词
Rpn10; prognosis; NE-kappa B; clear cell renal cell carcinoma; HEPATOCELLULAR-CARCINOMA; PROTEASOME; CANCER; MIGRATION;
D O I
10.1093/abbs/gmab078
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The ubiquitin-proteasome system (UPS) plays a central role in regulating protein homeostasis in tumor progression. The proteasome subunit Rpn10 is associated with the progression of several tumor types. However, little is known regarding the role of Rpn10 in clear cell renal cell carcinoma (ccRCC). In this study, we found that overexpression of Rpn10 increased ccRCC cell proliferation, migration, and invasion. Silencing Rpn10 expression resulted in decreased cell proliferation, migration, and invasion in ccRCC cells. Knockdown of Rpn10 inhibits tumor growth and cell proliferation in vivo. Furthermore, we demonstrated that Rpn10 increased cell proliferation, migration, and invasion via regulation of the nuclear factor kappa B (NE-kappa B) pathway. Rpn10 directly promoted inhibitor of nuclear factor-kappa B alpha (I kappa B alpha) degradation through the UPS. Moreover, we observed that upregulation of Rpn10 or downregulation of I kappa B alpha in ccRCC was associated with poor prognosis. We found that the combination of these two parameters was a more powerful predictor of poor prognosis than either parameter alone. Collectively, these findings provide evidence that Rpn10 promotes the progression of ccRCC by regulation of the NE-kappa B pathways and is a prognostic indicator for patients with ccRCC.
引用
收藏
页码:988 / 996
页数:9
相关论文
共 50 条
  • [21] IL1R2 promotes tumor progression via JAK2/STAT3 pathway in human clear cell renal cell carcinoma
    Liu, Yingting
    Xing, Zhaoyu
    Yuan, Maoling
    Xu, Bin
    Chen, Lujun
    Zhang, Dachuan
    Zhou, You
    Huang, Hao
    Zheng, Xiao
    Zhang, Jinping
    Jiang, Jingting
    PATHOLOGY RESEARCH AND PRACTICE, 2022, 238
  • [22] RAC2 acts as a prognostic biomarker and promotes the progression of clear cell renal cell carcinoma
    Liu, Yuenan
    Cheng, Gong
    Song, Zhengshuai
    Xu, Tianbo
    Ruan, Hailong
    Cao, Qi
    Wang, Keshan
    Bao, Lin
    Liu, Jingchong
    Zhou, Lijie
    Liu, Di
    Yang, Hongmei
    Chen, Ke
    Zhang, Xiaoping
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2019, 55 (03) : 645 - 656
  • [23] GAMT facilitates tumor progression via inhibiting p53 in clear cell renal cell carcinoma
    Zheng, Bin
    Liu, Kan
    Feng, Ji
    Ouyang, Qing
    Jia, Tongyu
    Wang, Yaohui
    Tian, Shuo
    Chen, Xinran
    Cai, Tianwei
    Wen, Lequan
    Zhang, Xu
    Li, Xiubin
    Ma, Xin
    BIOLOGY DIRECT, 2025, 20 (01)
  • [24] E2F3 upregulation promotes tumor malignancy through the transcriptional activation of HIF-2α in clear cell renal cell carcinoma
    Gao, Yu
    Li, Hongzhao
    Ma, Xin
    Fan, Yang
    Ni, Dong
    Zhang, Yu
    Huang, Qingbo
    Liu, Kan
    Li, Xintao
    Wang, Lei
    Yao, Yuanxin
    Ai, Qing
    Zhang, Xu
    ONCOTARGET, 2017, 8 (33) : 54021 - 54036
  • [25] Upregulation of PNCK Promotes Metastasis and Angiogenesis via Activating NF-κB/VEGF Pathway in Nasopharyngeal Carcinoma
    Chen, Xiaochuan
    Weng, Youliang
    Li, Ying
    Fu, Wankai
    Huang, Zongwei
    Pan, Yuhui
    Hong, Wenquan
    Lin, Wanzun
    Lin, Xiandong
    Qiu, Sufang
    JOURNAL OF ONCOLOGY, 2022, 2022
  • [26] TAB3 promotes human esophageal squamous cell carcinoma proliferation and invasion via the NF-κB pathway
    Zhao, Jiyi
    Gai, Ling
    Gao, Yi
    Xia, Wenkai
    Shen, Dong
    Lin, Qingfeng
    Mao, Weidong
    Wang, Fangjun
    Liu, Pengfei
    Chen, Jie
    ONCOLOGY REPORTS, 2018, 40 (05) : 2876 - 2885
  • [27] AURKC Promotes Clear Cell Renal Cell Carcinoma Proliferation Through Upregulation of ERp57
    Liu, Yan
    Wen, Yue
    Nie, Ziyuan
    Jia, Li
    JOURNAL OF CANCER, 2025, 16 (04): : 1215 - 1227
  • [28] CORO6 Promotes Cell Growth and Invasion of Clear Cell Renal Cell Carcinoma via Activation of WNT Signaling
    Wang, Xinjun
    Xiao, Yiming
    Li, Si
    Yan, Zhijian
    Luo, Guangcheng
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [29] P4HA3 promotes clear cell renal cell carcinoma progression via the PI3K/AKT/GSK3β pathway
    Zhang, Zhechuan
    Zhang, Yuanfeng
    Zhang, Ronggui
    MEDICAL ONCOLOGY, 2023, 40 (02)
  • [30] ATAD2 promotes glycolysis and tumor progression in clear cell renal cell carcinoma by regulating the transcriptional activity of c-Myc
    Wu, Zonglong
    Ge, Liyuan
    Song, Yimeng
    Deng, Shaohui
    Duan, Peichen
    Du, Tan
    Wu, Yaqian
    Zhang, Zhanyi
    Hou, Xiaofei
    Ma, Lulin
    Zhang, Shudong
    DISCOVER ONCOLOGY, 2023, 14 (01)